Literature DB >> 17131141

Impact of diabetes on haemoglobin levels in renal disease.

R Ravanan1, J R Spiro, P W Mathieson, R M Smith.   

Abstract

AIMS/HYPOTHESIS: Anaemia is a common complication of renal impairment. It has been suggested that renal failure secondary to diabetes is associated with more severe anaemia, but this has not been clearly substantiated in the published literature. To clarify this, we undertook a single centre, retrospective study to identify the impact of diabetes on anaemia associated with renal impairment.
MATERIALS AND METHODS: Information on clinical, biochemical and haematological parameters of 2,052 stable ambulatory patients attending a single tertiary referral renal unit was collected. The impact of diabetic kidney disease on haemoglobin levels at all degrees of renal impairment was studied by comparison with patients with non-diabetic kidney disease after correcting for other commonly associated variables that influence anaemia in patients with renal impairment.
RESULTS: Linear regression analysis showed lower haemoglobin in patients with diabetic kidney disease (p < 0.01). At chronic kidney disease (CKD) stages 3, 4 and 5, mean haemoglobin levels in patients with diabetic kidney disease compared with those in patients with non-diabetic kidney disease were 129.5 vs 136.9 g/l (p < 0.001), 120.5 vs 126.9 g/l (p < 0.001) and 107.1 vs 115.9 g/l (p < 0.01), respectively. At CKD stage 4 and 5 the two groups were comparable for ferritin, plasma intact parathyroid hormone levels, ACE inhibitor use and length of follow-up by a nephrologist. CONCLUSIONS/
INTERPRETATION: Diabetic kidney disease is associated with lower haemoglobin in comparison with non-diabetic kidney disease, especially at GFR <60 ml/min.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131141     DOI: 10.1007/s00125-006-0514-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  R-HuEPO hyporesponsiveness--who and why?

Authors:  T B Drüeke
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

2.  Abysmal prognosis of patients with type 2 diabetes entering dialysis.

Authors:  F Chantrel; I Enache; M Bouiller; I Kolb; K Kunz; P Petitjean; B Moulin; T Hannedouche
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

3.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

Authors:  M I Schmidt; B B Duncan; A R Sharrett; G Lindberg; P J Savage; S Offenbacher; M I Azambuja; R P Tracy; G Heiss
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

4.  Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.

Authors:  D R Bosman; C A Osborne; J T Marsden; I C Macdougall; W N Gardner; P J Watkins
Journal:  Diabet Med       Date:  2002-01       Impact factor: 4.359

5.  Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitors.

Authors:  S Ertürk; K Ateş; N Duman; O Karatan; B Erbay; E Ertuğ
Journal:  Nephrol Dial Transplant       Date:  1996-02       Impact factor: 5.992

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.

Authors:  Anupama Mohanram; Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Barry M Brenner; Robert D Toto
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

8.  Anemia in patients with type 1 diabetes.

Authors:  Merlin C Thomas; Richard J MacIsaac; Con Tsalamandris; Lynda Molyneaux; Inna Goubina; Greg Fulcher; Dennis Yue; George Jerums
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

9.  Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus.

Authors:  N T Richards; I Greaves; S J Lee; A J Howie; D Adu; J Michael
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

10.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  6 in total

1.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

Review 2.  Beyond chronic kidney disease: the diagnosis of Renal Disease in the Elderly as an unmet need. A position paper endorsed by Italian Society of Nephrology (SIN) and Italian Society of Geriatrics and Gerontology (SIGG).

Authors:  Filippo Aucella; Andrea Corsonello; Dario Leosco; Giuliano Brunori; Loreto Gesualdo; Raffaele Antonelli-Incalzi
Journal:  J Nephrol       Date:  2019-01-18       Impact factor: 3.902

3.  Anemia and Its Associated Factors Among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study.

Authors:  Mitku Mammo Taderegew; Tewodros Gebremariam; Amare Abera Tareke; Gashaw Garedew Woldeamanuel
Journal:  J Blood Med       Date:  2020-02-11

Review 4.  Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?"

Authors:  Giuseppina Crugliano; Raffaele Serra; Nicola Ielapi; Yuri Battaglia; Giuseppe Coppolino; Davide Bolignano; Umberto Marcello Bracale; Antonio Pisani; Teresa Faga; Ashour Michael; Michele Provenzano; Michele Andreucci
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 5.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14

6.  Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease.

Authors:  I-Ching Kuo; Hugo You-Hsien Lin; Sheng-Wen Niu; Jia-Jung Lee; Yi-Wen Chiu; Chi-Chih Hung; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.